|
KPNA6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.210600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.031200E-01 |
| Normal-vs-Stage2 |
7.282600E-01 |
| Normal-vs-Stage3 |
9.065400E-01 |
| Normal-vs-Stage4 |
7.412400E-01 |
| Stage1-vs-Stage2 |
9.058400E-01 |
| Stage1-vs-Stage3 |
3.765000E-01 |
| Stage1-vs-Stage4 |
2.887000E-01 |
| Stage2-vs-Stage3 |
6.345400E-01 |
| Stage2-vs-Stage4 |
5.376000E-01 |
| Stage3-vs-Stage4 |
8.337600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.987400E-01 |
| Normal-vs-AfricanAmerican |
4.441600E-02 |
| Normal-vs-Asian |
9.285000E-01 |
| Caucasian-vs-AfricanAmerican |
8.892000E-02 |
| Caucasian-vs-Asian |
7.935200E-01 |
| AfricanAmerican-vs-Asian |
7.856200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.559000E-01 |
| Normal-vs-Female |
5.934400E-01 |
| Male-vs-Female |
5.802400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.755200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.853800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.494000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.650000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.530000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.085000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.098200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.166800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.846800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.183800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.466600E-01 |
| Classical-VS-Follicular |
4.465000E-03 |
| Classical-VS-Other |
4.970000E-02 |
| Classical-VS-Normal |
1.986820E-01 |
| Tall-VS-Follicular |
5.323800E-01 |
| Tall-VS-Other |
1.577250E-01 |
| Tall-VS-Normal |
8.995800E-01 |
| Follicular-VS-Other |
3.682000E-01 |
| Follicular-VS-Normal |
3.673200E-01 |
| Other-VS-Normal |
1.149820E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.396200E-01 |
| Normal-vs-N1 |
2.676000E-01 |
| N0-vs-N1 |
2.461400E-01 |
|
|
